Results 91 to 100 of about 121,794,009 (205)

Blockade of Glutamate Release by Botulinum Neurotoxin Type A in Humans: A Dermal Microdialysis Study [PDF]

, 2014
BACKGROUND: The analgesic action of botulinum neurotoxin type A (BoNTA) has been linked to the blockade of peripheral release of neuropeptides and neurotransmitters in animal models; however, there is no direct evidence of this in ...
Rasmussen, Sten; id_orcid, Arendt-Nielsen, Lars, Lars Arendt-Nielsen, Ali Karshenas, da Silva, Larissa Bittencourt, Gazerani, Parisa; id_orcid, Larissa Bittencourt da Silva, Bach, Flemming W., Parisa Gazerani, Karshenas, Ali, Flemming W Bach, Sten Rasmussen   +11 more
core   +1 more source

Three players in the 'toxic affair' between botulinum neurotoxin type A and neurons

, 2023
Joensuu and colleagues have recently shown that botulinum neurotoxin (BoNT) type A exploits a heterotrimeric complex in the presynaptic membrane to bind to and enter neurons using a Trojan horse-like mechanism.
Marco Pirazzini, Montecucco, Cesare, Rossetto, Ornella, Cesare Montecucco, Pirazzini, Marco, Ornella Rossetto   +5 more
core   +1 more source

Comparison of botulinum neurotoxin type A formulations in Asia

, 2018
Jürgen Frevert,1 Ki Young Ahn,2 Mee Young Park,3 Owen Sunga4 1Merz Pharmaceuticals GmbH, Frankfurt, Germany; 2Dr. Ahn’s Plastic and Aesthetic Surgical Clinic, Daegu, South Korea; 3Department of Neurology, Yeungnam University School of Medicine,
Ahn KY, Park MY, Frevert J, Sunga O
core  

Use of Botulinum Neurotoxin in Ophthalmology

, 2016
Botulinum neurotoxin (BoNT) is the first biological toxin used in the treatment of ophthalmic diseases and to decrease skin wrinkles as an aesthetic agent.
Basar, Emel, Arici, Ceyhun, Ceyhun Arıcı, Emel Başar   +3 more
core   +1 more source

Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information

Toxins
The first-line management of cervical dystonia (CD) symptoms is intramuscular injection of botulinum toxin type A (BoNTA). However, a comparison of safety among BoNTAs is difficult because, per regulatory authorities, units of BoNTA activity are not ...
Khashayar Dashtipour, Han S. Lee, Aaron Ellenbogen, Rashid Kazerooni, Todd M. Gross, David A. Hollander, Conor J. Gallagher   +6 more
doaj   +1 more source

DEVELOPMENT OF ENZYME-LINKAGE IMMUNOSORBENT ASSAY AGAINST TYPE B OF CLOSTRIDIUM BOTULINUM: A PRELIMINARY STUDY [PDF]

Journal of the Indonesian Tropical Animal Agriculture, 2011
Clostridium botulinum neurotoxin (BoNTs) is one of the causes of economic loss in the livestock industry. This economic loss would be as a direct result when animals poisoned by BoNTs or indirectly when the livestock products are contaminated by BoNTs ...
S. N. Depamede, D. Kisworo
doaj  

Effect of pronator teres muscle botulinum neurotoxin type-A injection on proximal median nerve entrapment

Hand Surgery and Rehabilitation
We aimed to evaluate the effect of botulinum neurotoxin type-A (Btx-A) injection into the pronator teres muscle in proximal median nerve entrapment (PMNE).Intramuscular injection of 30 IU Btx-A into the pronator teres muscle was performed in 12 patients (14 extremities) diagnosed with PMNE. The injection was made under nerve stimulator control.
Ali, Özdemir, Ali, Güleç, Ahmet, Yurteri, Egemen, Odabaşı, Mehmet Ali, Acar   +4 more
openaire   +2 more sources

Botulinum Neurotoxin Type a Injection Combined with Absorbable Punctal Plug Insertion: An Effective Therapy for Blepharospasm Patients with Dry Eye. [PDF]

J Clin Med, 2023
Ndikumukiza M, Xiao YT, Ye YF, Wang JS, Peng X, Xie HT, Zhang MC.   +6 more
europepmc   +1 more source

Treatment of masseteric hypertrophy with botulinum toxin : a report of two cases [PDF]

, 2010
Masseter muscle hypertrophy is a rare condition of unknown cause which is important in the differential diagnosis of head and neck masses, located in the cheek.
Bas, Burcu, Muglali, Mehtap, B. Bas, Özan, Bora, Celebi, Nuekhet, Celebi, Nükhet, B. Ozan, M. Muglali, N. Celebi   +8 more
core   +1 more source

Botulinum neurotoxin formulations: overcoming the confusion

, 2018
Souphiyeh Samizadeh,1 Koenraad De Boulle2 1Great British Academy of Aesthetic Medicine, London, UK; 2Aalst Dermatology Clinic, Aalst, Belgium Abstract: Botulinum toxin A is produced by anaerobic spore-forming bacteria and is used for various therapeutic ...
De Boulle K, Samizadeh S
core